Association of unstable hemoglobin variants and heterozygous β- thalassemia: Example of a new variant HB acharnes or [β53(D4) Ala → Thr]

American Journal of Hematology

Volumn 62, Issue 3, 1999, Pages 186-192

  Papassotiriou, I ^a   Traeger Synodinos, J ^b   Prome D ^c   Kister, J ^d   Stamou, E ^a   Liakopoulou, T ^b   Stamoulakatou, A ^a   Kanavakis, E ^b   Wajcman, H ^e  

^a AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c Université Paul Sabatier   (France)

^d BICÊTRE HOSPITAL   (France)

^e HENRI MONDOR HOSPITAL   (France)

Author keywords

Hb variant; Oxygen binding; Thalassemia intermedia; Unstable hemoglobin

Indexed keywords

HEMOGLOBIN; OXYGEN;

ARTICLE; BETA THALASSEMIA; CASE REPORT; CHILD; DISEASE ASSOCIATION; ELECTROPHORESIS; FEMALE; HEMOGLOBIN ANALYSIS; HUMAN; MUTATION; OXYGEN AFFINITY; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; STRUCTURE ANALYSIS;

BETA-THALASSEMIA; CHILD; DNA; ERYTHROPOIETIN; FEMALE; HEMOGLOBINS, ABNORMAL; HUMANS; MUTATION; OXYGEN CONSUMPTION; RECEPTORS, TRANSFERRIN;

EID: 0032712115     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199911)62:3<186::AID-AJH9>3.0.CO;2-Z     Document Type: Article

References (27)

1. Cao A, Galanello R, Rosatelli MC. Genotype-phenotype correlations in β-thalassemias. Blood Rev 1994;8:1-12.
2. Cao A, Galanello R, Rosatelli MC. Pathologie moléculaire et diagnostic de la β-thalassemie intermédiaire. Hématologie 1995;4:289-294.
3. o-thalassemia: hematologic and functional consequences. Blood 1989;74:496-500.
4. Vassilopoulos G, Papassotiriou I, Voskaridou E, Stamoulakatou A, Premetis E, Kister J, Marden M, Griffon N, Poyart C, Wajcman H, Galacteros F, Loukopoulos D. Hb Arta [β45 (CD4) Phe → Cys]: a new unstable haemoglobin with reduced oxygen affinity in trans with β-thalassaemia. Br J Haematol 1995;91:595-601.
5. Wajcman H, Ducrocq R, Riou J, Mathis M, Godart C, Préhu C, Galacteros F. Perfusion chromatography on reversed-phase column allows fast analysis of human globin chains. Anal Biochem 1996;237: 80-87.
6. Huisman T. Methods. Hematol 1986;15:17-18.
7. Kister J, Poyart C, Edelstein SJ. An expanded two-state allosteric model for interaction of human hemoglobin A with nonsaturating concentrations of 2,3-diphosphoglycerate. J Biol Chem 1987;262:12085-12091.
8. Ericson A, de Verdier C. A modified method for the determination of 2,3-DPG in erythrocytes. Scand J Clin Lab Invest 1972;29:85-90.
9. Siggaard-Andersen M, Siggaard-Andersen O. Oxygen status algorithm, Version 3, with some applications. Acta Anaesthesiol Scand 1995;39(Suppl 107):13-20.
10. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16:1215.
11. Kanavakis E, Traeger-Synodinos J, Vrettou C, Maragoudaki E, Tzetis M, Kattamis C. Prenatal diagnosis of the thalassaemia syndromes by rapid DNA analytical methods. Mol Hum Reprod 1997;6:523-528.
12. Kanavakis E, Tzotzos S, Liapaki A, Metaxotou-Mauromati A, Kattamis C. Frequency of α-thalassemia in Greece. Am J Hematol 1986; 22:225-232.
13. Harteveld KL, Heister AJGAM, Giordano PC, Losekoot M, Bernini LF. Rapid detection of point mutations and polymorphisms of the α globin genes by DGGE and SSCA. Hum Mut 1996;7:114-122.
14. Wajcman H, Bardakdjian J, Ducrocq R. Structural characterization of abnormal hemoglobins from dried blood specimens in a neonatal screening program. Ann Biol Clin 1993;50:867-870.
15. Déon C, Promé JC, Promé D, Francina A, Groff P, Kalmes G, Galactéros F, Wajcman H. Combining mass spectrometry methods allows characterization of Human Hemoglobin variants localized within αT9 peptide: identification of Hb Villeurbanne α89 (FG1) His → Tyr. J Mass Spectrom 1997;32:880-887.
16. Ho P, Hall G, Luo L, Weatherall D, Thein S. β-Thalassaemia intermedia: is it possible consistently to predict phenotype from genotype? Br J Haematol 1998;100:70-78.
17. Traeger-Synodinos J, Kanavakis E, Vrettou C, Maragoudaki E, Michael T, Metaxotou-Mauromati A, Kattamis C. The triplicated α globin gene locus in β-thalassemm heterozygotes: clinical, haematological, biosynthetic and molecular studies. Br J Haematol 1996;95:467-471.
18. Thein SL. Dominant β-thalassaemia: molecular basis and pathophysiology. Br J Haematol 1992;80:273-277.
19. de Castro C, Devlin B, Fleenor D, Lee M, Kaufman R. A novel β globin mutation, βDurham-NC(β114 Leu → Pro), produces a dominant thalassemia-like phenotype. Blood 1994;83:1109-1116.
20. Fessas P, Loukopoulos D, Kokkinou S, Papassotiriou I, Karaklis A. Hemoglobin Knossos: A clinical, laboratory and epidemiological study. Am J Hematol 1986;21:119-133.
21. Winichagoon P, Thonglairoam V, Fucharoen S, Wilairat P, Fukumaki Y, Wasi P. Severity differences in β-thalassaemia/Hb E syndromes: implication of genetic factors. Br J Haematol 1993;83:633-639.
22. Williamson D. The unstable haemoglobins. Blood Rev 1993;7:146-163.
23. Wallach J. Interpretation of diagnostic tests. 5th edition. Boston: Little, Brown and Co.; 1992. p 270.
24. Cazzola M, Beguin Y. New tools for clinical evaluation of erythron function in man. Br J Haematol 1992;80:278-284.
25. Beguin Y, Clemons GK, Pootrakul P, Fillet G. Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin. Blood 1993;81:1067-1076.
26. Papassotiriou I, Traeger-Synodinos J, Kanavakis E, Karagiorga M, Stamoulakatou A, Kattamis C. Erythroid marrow activity and hemoglobin H levels in Hb H disease. J Ped Hematol/Oncol 1998; in press.
27. Joy Ho P, Wickramasinghe S, Rees D, Lee M, Eden A, Thein SL. Erythroblastic inclusions in dominantly inherited β-thalassemias. Blood 1997;89:322-328.